← Leaderboards
Dongze Zhang
University Of Nebraska Medical Center
$1,297,724
Attributed
$2,170,197
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $824.7K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$2,170,197 · 2
By mechanism
R01$1,744,947 · 1
R21$425,250 · 1
Top collaborators
- Yu-Long Li3 shared
Most similar at University Of Nebraska Medical Center
Same institution · by research overlap
- Hanjun Wang$9,874,791
- Yu-Long Li$10,009,035
- Rakesh K Singh$2,572,515
- Irving H Zucker$21,983,867
- Bin Duan$1,739,996
Others in their field
Other Rising Stars on “Miniaturize”
- Joseph Fraser Glickman · Hackensack University Medical Center$8,363,749
- Andrew Gardiner · Libero Pharma Limited$6,351,015
- Farshad Tehrani · Actiox Llc$5,931,530
- Ujjini Havaldar Manjunatha · University Of Texas Med Br Galveston$4,091,689
- David Jackson · Ceria Therapeutics, Inc.$4,064,867
- Sara P Chavarria · University Of Arizona$3,479,770
Research focus
MiniaturizeOpsinInfectionLinkNeuronsNovel Therapeutic InterventionDependovirusImproved OutcomeGenesLightNerveNeuronal ExcitabilityCardiacArrhythmiaAnimalsCellsGeneticConsciousAnti-Arrhythmia AgentsDesignGangliaIn VivoMortalityOptogenetics
Grant awards (5)
Optogenetic silencing to achieve antiarrhythmic effect of renal denervation in chronic heart failure$581,065
R01 · FY2025 · HL
Optogenetic silencing to achieve antiarrhythmic effect of renal denervation in chronic heart failure$569,442
R01 · FY2024 · HL
Optogenetic modulation of cardiac vagal function improves prognosis in diabetes$195,000
R21 · FY2024 · HL · contact PI
Optogenetic silencing to achieve antiarrhythmic effect of renal denervation in chronic heart failure$594,440
R01 · FY2023 · HL
Optogenetic modulation of cardiac vagal function improves prognosis in diabetes$230,250
R21 · FY2023 · HL · contact PI